Veraxa Biotech AG - Post de-SPAC VRXA
NASDAQ VRXA
$1.11 -0.09 (-7.14%)
As of: Oct 2, 2026 · 11:03 AM EDT

Veraxa Biotech AG - Post de-SPAC (VRXA) Liabilities and Shareholders Equity (2024 - 2025)

Updated

Veraxa Biotech AG - Post de-SPAC (VRXA) posted Liabilities and Shareholders Equity of $101.12 million for the quarter ended Dec 31, 2025, up 4.5% from $96.76 million a year earlier.

Analysis

Veraxa Biotech AG - Post de-SPAC (VRXA) Liabilities and Shareholders Equity (2024 - 2025) Analysis & Trends

As of Dec 31, 2025, Veraxa Biotech AG - Post de-SPAC's Liabilities and Shareholders Equity came in at $97.48 million, up 1.2% from the prior year.

  • In prior years, Veraxa Biotech AG - Post de-SPAC's Liabilities and Shareholders Equity was $96.35 million in the year ended Dec 31, 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 201.06 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 135.12 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 129.80 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 122.03 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 115.83 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 95.64 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 49.36 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 201.13 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 27.42 Bn
10 Veraxa Biotech AG - Post de-SPAC 18.09 Mn 14.68 Mn - 101.12 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 101.12 Mn
Dec 31, 2024 96.76 Mn
API Access

Veraxa Biotech AG - Post de-SPAC Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=VRXA&period=max&api_key=YOUR_API_KEY